Executive Summaries Jan 22, 2019

What Issues Can Arise During a Series A Financing Round?

There are a number of financing options available to a company seeking external financing at its early stages or to sustain its growth. 

It is important that a company properly understands the various forms of financing available and assess them according to its needs, objectives, stage of maturity, sector of activity and other important factors. This article focuses only on venture capital financing — an option preferred by a number of innovative and high-growth companies (for purposes of this article, a “company”).

Venture capital financing may be required at various stages of the company’s development and depending on its stage of maturity. These different types of financing are referred to as follows, their respective names reflecting the development stages of the companies seeking funding:

1. Pre-seed capital, 
2. Seed capital, and 
3. Series A, B, C (and any subsequent) rounds.

For the purposes of this article, we will focus on the Series A financing round, which is the first round of venture capital financing after the raising of pre-seed or seed capital, if any (kindly refer to our previous article which specifically addresses this form of investment). A Series A financing round is significant as it often focuses on the company’s growth and the funds raised generally range between $2M and $15M, although they may be higher. At this point, the company is usually in the optimization stage, experiencing and pursuing strong growth and moving towards “scalability”.

What Are the Typical Issues in a Series A Financing Round?

In a Series A financing round, the investors involved are mostly venture capital funds, i.e. sophisticated investors with a strong understanding of the issues related to their investments. 

Unlike in the pre-seed and seed rounds, investors at this stage want a bigger say in the company’s affairs.

It is important that the founders have sufficient knowledge and adequate understanding of the issues when negotiating with the investors in a Series A financing round, in addition to consulting with advisors who have extensive experience in this field. Here are some of the issues that can be encountered during a Series A financing round.

Due Diligence

During a Series A financing round, as in the pre-seed and seed rounds, investors will insist on conducting due diligence, which, although it may vary in scope, will generally be fairly thorough at this stage. A well organised, well documented and legally orderly company facilitates the process.

Valuation/Dilution

After the issuance of shares to the investors, the founders will hold a smaller percentage of shares than before; this is known as “dilution.” The company’s valuation is therefore an important factor, as the number and value of the shares issued to the investors will depend on it. It is also important to clarify from the outset whether the valuation is pre-money or post-money, to avoid (bad) surprises. A pre-money valuation refers to the value of the company before the investment and, conversely, a post-money valuation includes the amount of the investment. In any case, the higher the valuation, the less dilution for the founders. On the investors’ side, a lower valuation gives them a bigger stake in the company for the same amount invested.

Board of Directors

In a Series A financing round, the investors, or at least the major investors in that round, generally expect to be represented on the company’s board of directors. Some may insist on the right to appoint observers. In this respect, the founders’ priority should be to maintain control of the board of directors.

Veto Rights

Following a Series A financing round, the investors usually hold a minority stake in the company and do not control the board of directors. They therefore generally insist on a veto right (so as to block a decision) over a number of the company’s decisions, such as the amendment of its governing documents, the creation and issuance of new shares, the redemption of shares, and the sale of the business. This list can be considerably extended following the investors’ requests and can be subject to negotiation with the founders, who will wish to retain control over the majority of the company’s decisions and maintain their latitude.

Anti-dilution

Some investors insist on having some form of anti-dilution protection against any possible share issuance at a valuation lower that the one to which they subscribed. There are a number of mechanisms, sometimes quite complex, that provide for this type of protection, which can be the subject of heavy negotiations between investors and founders. 

Liquidation Preference

To assure that the amounts invested have some degree of protection, investors often insist on obtaining a preferential right in the case of a liquidity event, in the form of an amount of money expressed as a multiple of the initial investment, which they are entitled to receive should such event arise. The value of this multiplier must be negotiated and the definition of “Liquidity Event” must be agreed upon by the parties (such definition often refers to a subsequent investment, the sale of the business, a public offering or any other liquidity event).

Other Rights

Investors also generally insist on several other rights that are found in the shareholders’ agreement. If a shareholders’ agreement is already in place, the investors will insist on amending it or terminating it and drafting a new agreement so they can include certain specific rights. Such rights will often include pre-emptive rights, rights of first refusal, piggyback rights, and drag-along rights. Shareholders’ agreements require careful negotiations by the parties’ legal counsels.

Future Rounds of Financing

There is a possibility that the company will resort to subsequent rounds of financing. This reality can have various impacts on both investors and founders. For example, will the investors have the option or the obligation to subscribe for additional shares in these future rounds? If so, according to what terms? These concerns are usually addressed in the shareholders’ agreement and need to be analysed by the parties’ legal counsels.

Key Takeaway 

A Series A financing round can be crucial to a company’s growth and have many positive benefits, but it also entails its share of issues. Some of these are summarily dealt with above but, in reality, can prove to be very complex. There are also a number of other considerations and factors to take into account during a Series A financing round. In that context, BCF’s venture capital team assists clients and helps them fully understand and address these issues.

 

To learn more about venture capital, sign up for our Strategic Forum on Corporate Financing, which will be held on Tuesday, February 19, 2019 in Montreal and Quebec City.

You would also like

Financial_Markets_BCF

Key shortcomings identified in examinations, continuous disclosure documents, and prospectuses

Rencontre au Sommet

Rencontre au Sommet: Turning Economic Challenges into Collective Opportunities

Laboratoire

Epitopea and MSD join forces to advance immuno-oncology research

Entrepreneurship forum

Entrepreneurship Forum: Vision 2025

Tech Forum 360

Tech 360 Forum: Growth and Inflection Points

lexpert

28 Professionals Stand Out in the Canadian Legal Lexpert Directory 2024

Prospera: Québec’s Economic Barometer

Canada's Best Managed Companies: BCF Recognized for 17th Consecutive Year

deal

Damotech Receives Strategic Investment from Mountaingate Capital in its Transaction with Mac Rak

kitchen-blue-pots

Doyon Després Acquires First Branch Outside Québec

BCF extends its Partnership with the Canadian Association of Black Lawyers to a Third Year

Chambers Canada Ranking: Five of our Lawyers Recognized

Photo of Julie Doré

Julie Doré Takes Over Management of The BCF Business Law Firm

BCF Welcomes Five New Up-and-Coming Lawyers

Prospera – Quebec Economic Barometer

Julien Tricart, Member of the Meritas Sports Law Group

Launches of Neomabs Biotechnologies, a Company Dedicated to Developing New Immunotherapies For Cancer Treatment

Four new shareholders take over Groupe RCM

Pride Month: Let’s Create an Inclusive Future

Canada’s Best Managed Companies: BCF Recognized for 16th Consecutive Year

NCP Capital Partners Acquires Majority Stake in Manufacturer WR Transformers Inc.

OMY Laboratories secure $11 million in financing to expand into the North American cosmetics market

The non-profit organization SOLIDES gets its hands on 363 doors in a major transaction to curb the housing crisis in Drummondville

Every Woman Counts

Strategic Forum on the Role Played by Businesses in the Fight Against Climate Change

BCF Partners with the Canadian Association of Black Lawyers to Promote Diversity in Québec Law Faculties

BCF's More Inclusive Approach: Improved Parental Leave

From Renowned Athlete to Prestigious Lawyer: Focus on a Non-Traditional Legal Career Path

Shaun E. Finn Appointed to the Superior Court of Québec

How to Ensure a Business Succession?

Athos Commemorative Services Acquires Les Espaces Memoria Inc.

OPTEL Obtains Support from Fondaction and BDC Capital to Realize its Growth Projects

Strategic Forum on Market Consolidation and Business Succession

BCF Partners with the Clinique Juridique de Saint-Michel to Promote Access to Legal Studies for Young People from Diverse Communities

43 BCF Professionals Stand Out with 78 Nominations in the 2023 Editions of Best Lawyers in Canada and Ones to Watch

Adoption of Bill 96: Be Ready

Pride Month: The Value of Diversity

Strategic Alliance between Desjardins Capital and Orthogone Technologies

BCF, the 3rd Largest Law Firm in Québec

Canada’s Best Managed Companies: BCF Recognized for 15th Consecutive Year

See What Others Don’t: Solutions to Labour Shortage

Geneviève Martin Recognized as a Lexpert Rising Star 2021

Sportscene Group Enters Into a Privatization Agreement for a Cash Consideration of $7.25 Per Share

BCF Welcomes Julien Lefebvre as a Partner in its Business Law Team

PayFacto announces Equity Investment by Flexpoint Ford and BMO Capital Partners

IFLR1000 Canada: BCF Recognized Once Again as one of the top Corporate and Finance law Firms in Quebec

46 Lawyers of BCF Stand Out with 83 Recognitions in the 2022 Editions of Best Lawyers in Canada and Ones to Watch

Seven New Lawyers Join BCF

150 Million in Investments for Fonds QScale S.E.C.

New Venture Capital Fund Created in Partnership with Centech

Our Partners Stand Out in the Canadian Legal Lexpert Directory

Economic Recovery Strategic Forum

NCP Capital Partners Acquires a Majority Stake in Beauce Caoutchouc Inc. and its Subsidiary UCB Inc.

Adoption of Bill 42: Mandatory Disclosure of Nominee Agreement with Tax Consequences

Equity Crowdfunding in Canada: What You Need to Know about the Latest Regulatory Changes

23 BCF Partners Ranked in the Canadian Legal Lexpert Directory

36 Lawyers of BCF Stand Out with 52 Nominations in the 2021 Edition of Best Lawyers in Canada

Equity Crowdfunding: An Alternative to Traditional Financing Not Enough Used by SMEs

BCF Welcomes Six New Lawyers in its Team

IFLR1000 Canada: BCF Ranked Among Quebec’s Leading Financial and Corporate Law Firms

Maibec Acquires CanExel Brand

COVID-19: Tax and Financial Measures Announced in Response to the Pandemic

COVID-19: Managing Your Liquidity and Cash Flow

A Major $145 Million Investment for Alliance Magnesium

Areas of Innovation to Generate Growth

You seek investors? Prepare adequately

Private Equity: Fueling Canada’s Growth

Reverse Takeovers: An Alternative to the Traditional Initial Public Offering

Do Quebec Businesses Attract Foreign Investors?

Foreign Investment Strategic Forum

Trudel Alliance Buys 7 Shopping Centres in Quebec City for $165M

Are You a Leader or a Follower?Results of the Innovation Survey

Infrastructure and Major Projects: Dare to Think Big

Strategic Forum on Innovation

Innovating to Survive: Are You a Leader or a Follower?

BCF represented TeraXion Inc. in a major transaction

Humania Assurance Acquires All the Assets of Tour+Med

Best Lawyers in Canada: 22 BCF Lawyers Recognized

Prevtec Microbia to be Acquired by Elanco

Health Canada Is Changing its Cannabis Licensing Process

16 BCF Partners Recognized in the Prestigious Canadian Legal Lexpert Directory

lunettes

Is Canadian Taxation Fair?

jumelles-de-vue

In The Globe and Mail this Week: Stock Exchange Listings, Unsolicited Bids, and Talent Attraction

Corporate Financing Strategic Report

multicolor

Targeting an IPO in 2019? What Unicorns Should Expect

voilier

A Flexible Tool to Support a Company’s Growth: Mezzanine Debt

pont-en-dessus

How Did Venture Capital Fare in Quebec in 2018 and What Can We Expect to See Next?

escalier

How to Go About Pre-seed and Seed Funding?

palais-justice

The Canadian Securities Commission?

vitesse

Capital Pool Companies: A Little-Known But Effective Financing Vehicle

agriculture

Public funding in the cannabis industry

piliers

Can a Demand for Share Redemption Lead to a Loss of Shareholder Attributes?

structure-beton

The Impact of Restrictive Covenants When Obtaining Bank Financing

design-immeuble

Venture capital financing instruments: Which way to go?

immeubles-sans-logo-bonne-dimension

Corporate Financing Strategic Forum

BCF Ventures Doubles its Potential Size to $12 million and Presents its Portfolio

Good AI Capital: the First Silicon Valley-Based Venture Fund to Settle in Québec

Obtaining Financing and the Inherent Challenges of the Cannabis Industry

Get the latest thought leadership